This is the latest clinical trial for CLE in Gastroenterology and is being used in conjunction with a Pentax Iscan HD endoscope. It must be galling for Pentax that a Mauna Kea probe is being used when Pentax had an embedded system using the OIL scope. In any event the door is still open for Optiscan when they get back to their probe after the work on Zeiss and MR Solutions is complete. CLE was always to be used in conjunction with HD scopes to better target the need for biopsy. Pentax must surely watch this trial with interest and might again come knocking at the door of Optiscan!!
https://clinicaltrials.gov/ct2/show/NCT02481687
"Because of its minute scanning area, this techology is best used in conjunction with other "red-flag" techniques to screen the mucosa for areas of interest, which can then be examined by CLE for a histological diagnosis"
- Forums
- ASX - By Stock
- OIL
- pentax and CLE
OIL
optiscan imaging limited
Add to My Watchlist
1.19%
!
8.5¢

pentax and CLE
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.5¢ |
Change
0.001(1.19%) |
Mkt cap ! $71.00M |
Open | High | Low | Value | Volume |
8.3¢ | 8.5¢ | 8.1¢ | $10.90K | 132.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 125000 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 125000 | 0.080 |
2 | 76500 | 0.079 |
2 | 130000 | 0.078 |
1 | 10000 | 0.075 |
1 | 41680 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 60000 | 1 |
0.090 | 15000 | 1 |
0.092 | 50000 | 1 |
0.095 | 50000 | 1 |
0.100 | 103621 | 2 |
Last trade - 15.36pm 19/09/2025 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |